CClinicalTrials.gg
Sign In
CompletedNCT00564239Updated Apr 30, 2018

Psychological Prevention of Internalizing Disorders

An interventional study of Cognitive Behavioral Group Therapy and Cognitive Behavioral Group Therapy in Anxiety Symptoms, Depressive Symptoms and Somatoform Symptoms, sponsored by Philipps University Marburg. Completed at 1 site in Germany. Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2018-04-30.

Sponsored by Philipps University Marburg · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
8 Years to 12 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcome.

Read the detailed description

Internalizing disorders represent a large group of psychological disorders among children who are referred to psychological treatment. Anxiety, Depression and somatoform disorders in children and adolescents increase the risk of mental disorders in adulthood. Some english programs have proved the efficacy of CBT-G prevention.This study will test the efficacy of CBT-G in German children. The role of parental involvement is currently subject to scientific discussions. The impact of an additional parent-group training will be investigated.

02

Conditions studied

  • Anxiety Symptoms
  • Depressive Symptoms
  • Somatoform Symptoms

Browse trials for

03

In context

Depression

8,055 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's enrollment of 77 is close to the median of 84 across 6,718 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Philipps University Marburg is the lead sponsor of 114 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 8- 12 years and
  • anxiety symptoms and/or
  • depressive symptoms and/or
  • somatoform symptoms

Exclusion criteria

Exclusion Criteria:

  • psychiatric disorder according to ICD-10/ DSM-IV-TR requiring individual psychotherapy
  • IQ \< 85
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    A

    Behavioral: Cognitive Behavioral Group Therapy

  • Active comparator
    B

    Behavioral: Cognitive Behavioral Group Therapy

  • No intervention
    C

Interventions

  • BehavioralCognitive Behavioral Group Therapy

    12 children group sessions, 8 parent group sessions

  • BehavioralCognitive Behavioral Group Therapy

    12 children group sessions

06

What researchers measure

Primary outcomes

  1. Child Behavior Checklist (german version)

    Time frame: 3, 6, 18 months

Secondary outcomes

  1. Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK)- Assessment of life quality, parent and child versions

    Time frame: 3, 6, 18 months

  2. Spence Children's Anxiety Scale (SCAS)

    Time frame: 3, 6, 18 months

  3. Depressionsinventar für Kinder- und Jugendliche (DIKJ), german depression inventory based on CDI

    Time frame: 3, 6, 18 months

  4. Giessener Beschwerdebogen für Kinder- und Jugendliche (GBB-KJ), report of somatic symptoms, parent and child versions

    Time frame: 3, 6, 18 months

  5. Culture Fair Intelligence Test (CFT 20-R)

    Time frame: initially

  6. Symptom-Checklist (SCL-90-R), german version

    Time frame: 3, 6, 18 months

07

Study locations

1 site
  • Institut für Verhaltenstherapie und -medizin (IVV)
    Marburg, Hessen D-35039, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00564239
Lead sponsor
Philipps University Marburg
Collaborators
Institute of Behavioral-Therapy and -Medicine at the Philipps University Marburg, Dept. of Child and Adolescent Psychiatry, Philipps University Marburg
Responsible party
Jan Pauschardt (Dr. rer. nat., Philipps University Marburg) — Principal investigator
First posted
Nov 27, 2007
Start date
Nov 2007
Primary completion
May 2009
Completion
May 2009
Last update
Apr 30, 2018

Study contacts

Jan Pauschardt, Dr.
principal investigator · Philipps University Marburg
Sylvia D Eimecke, Dr.
principal investigator · Philipps University Marburg
Fritz Mattejat, PhD
study director · Philipps University Marburg

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Depression→

Other studies from this sponsor

Philipps University Marburg

Start the discussion